4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021521
CHIEF EXECUTIVE OFFICER sold 40,000 shares at $62.00 ($2,480,000)
- CHIEF EXECUTIVE OFFICER acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Peetz Christopher · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $2.94 | $117,440 | 178,641 | D |
| 2025-08-11 | Sale : show line 2 in the form 10b5-1 | −40,000 | $62.00 | $2,480,000 | 138,641 | D |
| Open-market sales · 40,000 sh · avg $62.00 · $2,480,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-11 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −40,000 | 158,487 | D |
Loading xslF345X05/form4-08122025_110854.xml…